To add adequate controls, we also knockout miR-155 in two other cell lines, the NB4 cells (a FLT3 WT AML cell line) and HeLa cell line (Cervical Cancer-Solid tumor) and conduct MTT assay to test the sensitivity to ADM. This evidence concerns the gene FLT3 and cervical carcinoma.